MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ModivCare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MODV

Core Viewpoint - ModivCare, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding its financial performance and liquidity issues [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that ModivCare made false or misleading statements and failed to disclose that contract renegotiations and pricing accommodations negatively impacted its adjusted EBITDA [2]. - Additionally, it is alleged that ModivCare had insufficient liquidity during the class period [2]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased ModivCare securities during the class period to seek appointment as lead plaintiff in the lawsuit [3]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and acts on behalf of all class members [3]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud cases, having secured $6.6 billion for investors in such cases, significantly more than any other firm in the last four years [4]. - The firm has a strong track record, including the largest securities class action recovery in history, amounting to $7.2 billion in the Enron case [4].